Avanos Medical, Inc.
AVNS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $732,320 | $1,045,238 | $1,269,114 | $1,667,627 |
| - Cash | $107,700 | $87,700 | $127,700 | $118,500 |
| + Debt | $170,200 | $209,100 | $277,000 | $187,500 |
| Enterprise Value | $794,820 | $1,166,638 | $1,418,414 | $1,736,627 |
| Revenue | $687,800 | $673,300 | $684,100 | $744,600 |
| % Growth | 2.2% | -1.6% | -8.1% | – |
| Gross Profit | $381,300 | $379,700 | $394,200 | $379,900 |
| % Margin | 55.4% | 56.4% | 57.6% | 51% |
| EBITDA | -$345,600 | $50,600 | $77,800 | $48,900 |
| % Margin | -50.2% | 7.5% | 11.4% | 6.6% |
| Net Income | -$392,100 | -$61,800 | $50,500 | $6,300 |
| % Margin | -57% | -9.2% | 7.4% | 0.8% |
| EPS Diluted | -8.53 | -1.33 | 1.07 | 0.13 |
| % Growth | -541.4% | -224.3% | 723.1% | – |
| Operating Cash Flow | $100,700 | $32,400 | $90,900 | $87,300 |
| Capital Expenditures | -$17,800 | -$17,800 | -$19,300 | -$21,000 |
| Free Cash Flow | $82,900 | $14,600 | $71,600 | $66,300 |